1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 20th November 2023 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

t cells

Page 1 of 3
  1. EndME
    Thread

    Chikungunya-virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans, 2023, Chang et al

    Chikungunya-virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans Abstract Chikungunya virus...
    Thread by: EndME, Nov 22, 2023, 0 replies, in forum: 'Conditions related to ME/CFS' news and research
  2. SNT Gatchaman
    Thread

    [Preprint] ... Multi-omics study identifies immune programs associated with COVID-19 severity and mortality in hospitalized participants, 2023

    Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized...
    Thread by: SNT Gatchaman, Nov 11, 2023, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  3. EndME
    Thread

    SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells, 2023, Huot et al

    SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells Abstract Severe acute respiratory syndrome...
    Thread by: EndME, Nov 2, 2023, 1 replies, in forum: Long Covid research
  4. SNT Gatchaman
    Thread

    Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID, 2023, Wang et al

    Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID Kaiming Wang; Mobin Khoramjoo; Karthik...
    Thread by: SNT Gatchaman, Oct 30, 2023, 4 replies, in forum: Long Covid research
  5. SNT Gatchaman
    Thread

    A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling, 2023, Hackney et al.

    A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling [SPOILER] Altered myeloid inflammation...
    Thread by: SNT Gatchaman, Oct 11, 2023, 3 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  6. SNT Gatchaman
    Thread

    SARS-CoV-2 spike antigen-specific B cell and antibody responses in convalescent males and females with or without post-covid condition, 2023, Limoges+

    SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without...
    Thread by: SNT Gatchaman, Oct 10, 2023, 2 replies, in forum: Long Covid research
  7. EndME
    Thread

    The β1-adrenergic receptor links sympathetic nerves to T cell exhaustion

    The β1-adrenergic receptor links sympathetic nerves to T cell exhaustion Abstract CD8+ T cells are essential components of the immune response...
    Thread by: EndME, Sep 20, 2023, 2 replies, in forum: 'Conditions related to ME/CFS' news and research
  8. Mij
    Thread

    Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19, 2023, Harish Narasimhan et al

    Abstract The long-term health effects of SARS-CoV-2, termed Post-Acute Sequelae of COVID-19 (PASC), are quickly evolving into a major public...
    Thread by: Mij, Sep 15, 2023, 8 replies, in forum: Long Covid research
  9. Mij
    Thread

    Autoimmunity to synovial extracellular matrix proteins in patients with postinfectious Lyme arthritis, 2023, Korawit Kanjana et al

    BACKGROUND. Autoimmune diseases often have strong genetic associations with specific HLA-DR alleles. The synovial lesion in chronic inflammatory...
    Thread by: Mij, Sep 2, 2023, 8 replies, in forum: Infections: Lyme, Candida, EBV ...
  10. EndME
    Thread

    SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial, 2023, Yannaki et al

    SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial Abstract Despite advances, few therapeutics have shown...
    Thread by: EndME, Aug 19, 2023, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  11. Sly Saint
    Thread

    Gut-licensed β7+ CD4+ T cells contribute to progressive retinal ganglion cell damage in glaucoma 2023, Chong He et al

    Editor’s summary T cells are likely involved in glaucoma pathogenesis, but how they gain retinal access remains elusive. He and colleagues...
    Thread by: Sly Saint, Aug 4, 2023, 1 replies, in forum: Other health news and research
  12. Sly Saint
    Thread

    Review Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2023, Maya

    Abstract: Millions globally suffer from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The inflammatory symptoms, illness onset,...
    Thread by: Sly Saint, Jul 26, 2023, 0 replies, in forum: ME/CFS research
  13. Tom Kindlon
    Thread

    Preprint Comparison of T-cell Receptor Diversity of people with Myalgic Encephalomyelitis versus controls, 2023, Dibble, Ponting et al

    Pre-print Free fulltext: https://www.researchsquare.com/article/rs-3164397/v1 Comparison of T-cell Receptor Diversity of people with Myalgic...
    Thread by: Tom Kindlon, Jul 22, 2023, 20 replies, in forum: ME/CFS research
  14. Hutan
    Thread

    IIMEC 2023: Maureen Hanson

    IIMEC15 08 Professor Maureen Hanson 15th Invest in ME Research International ME Conference 2023 [MEDIA] 29 minutes Terrific presentation from...
    Thread by: Hutan, Jul 18, 2023, 41 replies, in forum: ME/CFS research news
  15. John Mac
    Thread

    Divergent adaptive immune responses define two types of Long COVID, 2023, Chakrabarti et al

    The role of adaptive immune responses in long COVID remains poorly understood, with contrasting hypotheses suggesting either an insufficient...
    Thread by: John Mac, Jul 3, 2023, 4 replies, in forum: Long Covid research
  16. SNT Gatchaman
    Thread

    [Preprint] Trained immunity in human monocyte enhances myeloid-T-cell pathogenic crosstalk in Ankylosing Spondylitis, 2023, Zhao et al.

    Trained immunity in human monocyte enhances myeloid-T-cell pathogenic crosstalk in Ankylosing Spondylitis Jinyi Zhao; Feng Liu; Claudia Worth;...
    Thread by: SNT Gatchaman, Jun 11, 2023, 0 replies, in forum: Other specific illnesses
  17. SNT Gatchaman
    Thread

    Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19, 2023, Sparks et al

    Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19 Sparks R, Lau WW, Liu C, Han KL, Vrindten KL, Sun G, Cox M, Andrews...
    Thread by: SNT Gatchaman, Mar 28, 2023, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  18. Andy
    Thread

    Preprint: Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2 2023 Yin et al

    Abstract Long COVID (LC), a type of post-acute sequelae of SARS-CoV-2 infection (PASC), occurs after at least 10% of SARS-CoV-2 infections, yet...
    Thread by: Andy, Feb 11, 2023, 5 replies, in forum: Long Covid research
  19. Braganca
    Thread

    Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2023, Maya et al

    https://www.mdpi.com/1422-0067/24/3/2010 Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling multisystem illness...
    Thread by: Braganca, Jan 19, 2023, 15 replies, in forum: ME/CFS research
  20. Sarah
    Thread

    Persistent post–COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium, 2022, Finlay JB

    Abstract: SARS-CoV-2 causes profound changes in the sense of smell, including total smell loss. Although these alterations are often transient,...
    Thread by: Sarah, Dec 22, 2022, 3 replies, in forum: Long Covid research
Showing results 1 to 20 of 58
Page 1 of 3